StockWatch
·

Kirloskar Industries Ltd Q2 FY27 Results

KIRLOSINDQ2 FY27 Results
Filing
Result:Steady· Market: Flat#Base effect#Margin squeeze
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.1K16.6%16.4%
Total Income2.1K16.6%17.2%
Expenditure1.9K16.5%17.6%
PBT158.4751.0%9.5%
Net Profit104.6032.8%6.2%
OPM11.65%1.22pp1.66pp
NPM4.99%0.61pp0.51pp
EPS48.9250.6%0.0%
View full financials

Core manufacturing/holding metric — adjusted PAT growth of ~8.9% YoY — trails revenue growth with margins contracting (EBITDA ~12.7% vs ~13.6%) and the NCI share rising faster than owners' PAT, making this an in-line, unremarkable quarter for the sector.

Q2 FY-2027 RESULTS · KIRLOSIND

Kirloskar Industries Q2FY27: consol PAT +6% YoY trails 16% revenue growth, NCI gains more

PAT +6.2% YoY · revenue +16.45% · margins flat

06 Nov 2026 · 3 min read
Revenue

₹2,075.02 Cr

+16.45% YoY

PAT (consolidated)

₹104.96 Cr

+6.2% YoY

Net margin

5%

-0.5pp YoY

EPS

₹48.92

Kirloskar Industries' consolidated (primary basis) revenue for Q2 FY27 came in at ₹2,075.0 Cr, up 16.4% YoY from ₹1,781.9 Cr and 16.6% QoQ from ₹1,779.2 Cr — growth driven almost entirely by subsidiary Kirloskar Ferrous Industries (KFIL), whose standalone revenue rose 17% YoY to ₹2,047 Cr on higher pig-iron and castings volumes (per KFIL's own Oct 31 filing). Consolidated PAT for the period was ₹104.6 Cr, up a more modest 6.2% YoY from ₹98.5 Cr — profit growth trailed revenue growth by a wide margin. Of that ₹104.6 Cr, only ₹51.0 Cr was attributable to Kirloskar Industries' own shareholders (down ~3% YoY from ₹52.6 Cr); the remaining ₹53.6 Cr went to non-controlling interests — chiefly KFIL's external shareholders — up from ₹48.2 Cr a year ago. For a holding company whose equity value rests on its share of subsidiary earnings, that NCI shift matters more than the consolidated PAT headline.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹2,075.02 Cr+16.6%+16.4%
Expenses₹1,939.23 Cr+16.5%+17.6%
PAT₹104.96 Cr+32.83%+6.2%
Net margin5%+0.6pp-0.5pp
EPS₹48.92+50.6%0%

QoQ, the 32.8% jump in PAT (from ₹78.8 Cr) is largely optical: Q1 FY27 absorbed a ₹29.3 Cr exceptional expense that does not repeat this quarter, while Q2 FY26 itself carried a ₹3.7 Cr exceptional gain. Adjusting both sides, YoY PAT growth runs closer to ~8.9% and QoQ growth to roughly ~7% — still positive, but nowhere near the headline swings suggest. Net profit margin recovered to 5.04% of revenue from a depressed 4.4% in Q1 FY27, but remains below the 5.6% logged a year ago; the group's own EBITDA margin (computed from the expense breakup) eased to ~12.7% from ~13.6% YoY, pointing to continued, if mild, cost/input pressure rather than a one-quarter blip.

₹
2,919.293,205.293,491.33,777.314,063.313,36808-0308-2509-1710-1211-0411-06Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹3,368, down 4.3% over the past month of trading.

₹ Cr
041.282.39123.5995.48Q1 FY26rev ₹1,705 Cr98.49Q2 FY26rev ₹1,782 Cr49.45Q3 FY26rev ₹1,624 Cr110.35Q4 FY26rev ₹1,827 Cr78.75Q1 FY27rev ₹1,779 Cr104.6Q2 FY27rev ₹2,075 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

No consensus estimates for Kirloskar Industries or KFIL's Q2 FY27 print turned up in available coverage — both are thinly tracked, with only scattered price-target notes on KFIL from a couple of brokerages — so vs-Street is unknown rather than a beat or miss. The company carries no formal prior guidance or outlook on record in our data, and none surfaced in web coverage either, so the usual guidance-grading angle does not apply this quarter; no separate management press release or commentary was available for this filing beyond the regulatory disclosures. The quarter's other corporate action was governance, not financial: the Board re-appointed Aditi Chirmule as Executive Director for a further three years from 25 January 2027 and named Amarjeet Singh (ex-KOEL) as VP–HR & Corporate Affairs effective 6 November 2026, both disclosed in the same filing as the results but unconnected to the P&L.

  • W1

    Whether KFIL's margin recovery continues — consolidated EBITDA margin ~12.7% this quarter vs ~13.6% a year ago; next quarter's print will show if the gap closes.

  • W2

    NCI's share of consolidated profit has exceeded owners' share in 2 of the last 3 quarters (₹53.6 Cr vs ₹51.0 Cr this quarter) — track whether shareholders' own PAT share stabilises relative to NCI.

  • W3

    No formal guidance is on record; H1 FY27 PAT of ₹183.4 Cr is ~36% of FY26's full-year ₹503.2 Cr — watch whether the run-rate holds through H2.

Figures above are continuing-operations basis (statement splits continuing/discontinuing ops). Standalone total PAT incl. discontinued ops = ₹41.12 Cr (total EPS ₹39.13); consolidated total PAT incl. discontinued ops = ₹104.60 Cr (total EPS ₹48.58), of which ₹51.04 Cr attributable to owners and ₹53.56 Cr to non-controlling interest. No exceptional item this quarter; Q1 FY27 carried a ₹29.33 Cr exceptional expense and Q2 FY26 a ₹3.74 Cr exceptional gain (both continuing ops, consolidated).

Informational and educational content only. Not investment advice.